Menú Close

Artículos sobre Moderna vaccine

Mostrando todos artículos

Joe Biden, then president-elect, received his COVID-19 vaccination in December. Joshua Roberts via Getty Images

Can Biden fix the vaccine mess? An expert says yes

The COVID-19 vaccine rollout has fallen far short of President Trump's promises. President Biden says he can fix that. Can he?
Health-care workers wait in line at a COVID-19 vaccine clinic in Toronto on Jan. 7, 2021. THE CANADIAN PRESS/Nathan Denette

COVID-19 vaccine rollout: Why a mask and social distancing are still needed, even if you get the shot

Rollout of COVID-19 vaccines has begun. But getting the jab doesn't mean abandoning masks, distancing and handwashing. Here's why the current preventive measures must continue post-vaccine.
If too many Americans refuse to take the COVID-19 vaccine, achieving population immunity will be difficult. Paul Hennessy/NurPhoto via Getty Images

Americans have unrealistic expectations for a COVID-19 vaccine

Two in five Americans say they don't want a COVID-19 vaccine, which is a problem. Finding out what Americans do want from a vaccine might help.
Seniors in Fort Myers, Fla. wait for their COVID-19 vaccinations. At this site, 800 doses of vaccine were available. Octavio Jones via Getty Images

Vaccine delays reveal unexpected weak link in supply chains: A shortage of workers

The shipment of goods to suppliers has become technologically sophisticated. Delays in getting out the COVID-19 vaccine to people show that the breakdowns come down to something more basic.
The number one scientific breakthrough for 2020: multiple vaccines to prevent COVID-19. Philippe Raimbault/Photodisc via Getty Images

The top scientific breakthrough for 2020 was understanding SARS-CoV-2 and how it causes COVID-19 – and then developing multiple vaccines

The development of multiple vaccines against the virus that causes COVID-19 has been hailed as the breakthrough of 2020. But there were many more supporting discoveries that made this possible.
The pharmaceutical industry opposes the suspension of intellectual property rights on COVID-19 vaccines and treatments, and no pharma companies have yet contributed to the COVID-19 Technology Access Pool. (Shutterstock)

Can a pharma company change? Profit, not altruism, motivates COVID-19 vaccine development

We should applaud drug companies for developing COVID-19 vaccines in record time, but let’s not be under any illusion about the profits that are motivating them.
A nurse prepares a shot for a clinical trial of a COVID-19 vaccine candidate developed by the National Institutes of Health and Moderna Inc., on July 27, 2020 in Binghamton, N.Y. (AP Photo/Hans Pennink, File)

COVID-19 vaccine FAQ: 6 things to look for in clinical trial results

With COVID-19 vaccine announcements making headlines, non-scientists need to know what clinical trial results mean. Here are some key points to look for in vaccine trial reports.
The drug maker company Pfizer says its COVID-19 vaccine is 95% effective with no serious side effects. Eduardo Munoz Alvarez/VIEW press/Corbis News via Getty Images

Coronavirus vaccines: health experts identify ways to build public trust

The United Nations recently asked a group of experts across the world to recommend ways to persuade people to take a COVID-19 vaccine. Here is a summary of their suggestions.

Principales colaboradores

Más